These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6337580)

  • 21. Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study.
    Bloch M; Schwartzman Y; Bonne O; Lerer B
    J Clin Psychopharmacol; 1997 Feb; 17(1):44-8. PubMed ID: 9004056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating bulimia with desipramine. A double-blind, placebo-controlled study.
    Hughes PL; Wells LA; Cunningham CJ; Ilstrup DM
    Arch Gen Psychiatry; 1986 Feb; 43(2):182-6. PubMed ID: 3511878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: a controlled, prospective study.
    Wroblewski BA; Joseph AB; Cornblatt RR
    J Clin Psychiatry; 1996 Dec; 57(12):582-7. PubMed ID: 9010122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced REM latency predicts response to tricyclic medication in depressed outpatients.
    Rush AJ; Giles DE; Jarrett RB; Feldman-Koffler F; Debus JR; Weissenburger J; Orsulak PJ; Roffwarg HP
    Biol Psychiatry; 1989 May; 26(1):61-72. PubMed ID: 2655719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can mildly depressed outpatients with atypical depression benefit from antidepressants?
    Stewart JW; McGrath PJ; Quitkin FM
    Am J Psychiatry; 1992 May; 149(5):615-9. PubMed ID: 1575250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression.
    Mason BJ; Kocsis JH; Ritvo EC; Cutler RB
    JAMA; 1996 Mar; 275(10):761-7. PubMed ID: 8598592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of desipramine in mildly depressed patients: a double-blind, placebo-controlled trial [proceedings].
    Stewart JW; Quitkin F; Liebowitz MR; McGrath PJ; Klein DF
    Psychopharmacol Bull; 1981 Jan; 17(1):136-8. PubMed ID: 7015394
    [No Abstract]   [Full Text] [Related]  

  • 29. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
    Emslie GJ; Rush AJ; Weinberg WA; Kowatch RA; Hughes CW; Carmody T; Rintelmann J
    Arch Gen Psychiatry; 1997 Nov; 54(11):1031-7. PubMed ID: 9366660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desipramine for the treatment of "pure" dysthymia versus "double" depression.
    Marin DB; Kocsis JH; Frances AJ; Parides M
    Am J Psychiatry; 1994 Jul; 151(7):1079-80. PubMed ID: 8010368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of adinazolam and desipramine in the treatment of major depression.
    Kennedy SH; de Groot J; Ralevski E; Reed K
    Int Clin Psychopharmacol; 1991; 6(2):65-76. PubMed ID: 1960382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind placebo-controlled multicenter evaluation of the efficacy and safety of nomifensine in depressed outpatients.
    Goldstein BJ; Brauzer B; Kentsmith D; Rosenthal S; Charalampous KD
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):52-5. PubMed ID: 6370975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance therapy for chronic depression. A controlled clinical trial of desipramine.
    Kocsis JH; Friedman RA; Markowitz JC; Leon AC; Miller NL; Gniwesch L; Parides M
    Arch Gen Psychiatry; 1996 Sep; 53(9):769-74; discussion 775-6. PubMed ID: 8792753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.
    Joffe RT; Singer W; Levitt AJ; MacDonald C
    Arch Gen Psychiatry; 1993 May; 50(5):387-93. PubMed ID: 8489327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter placebo-controlled evaluation of nomifensine treatment in depressed outpatients.
    Feighner JP; Merideth CH; Claghorn JL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):47-51. PubMed ID: 6370974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.
    Feiger AD; Heiser JF; Shrivastava RK; Weiss KJ; Smith WT; Sitsen JM; Gibertini M
    J Clin Psychiatry; 2003 Mar; 64(3):243-9. PubMed ID: 12716264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response.
    Swann AC; Bowden CL; Rush AJ; Rhoades H; Rose R; Kobes R
    J Clin Psychopharmacol; 1997 Apr; 17(2):78-83. PubMed ID: 10950467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
    McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
    Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.